Rethinking benefit sharing in collaborative human genetic research from an Afrocommunitarian perspective.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. When genomics companies act as biobanks: governance challenges in an era of genomic assetization.Frontiers in genetics · 2026
   Article
2. Data as scientific currency: Challenges experienced by researchers with sharing health data in sub-Saharan Africa.PLOS digital health · 2024
   Article
3. Webinar report: stakeholder perspectives on informed consent for the use of genomic data by commercial entities.Journal of medical ethics · 2023
   Article
4. Decolonial health literature can increase our thinking about ethics dumping.Journal of medical ethics and history of medicine · 2023
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors.

Funding

Abstract

Indexed as